Simplifying Global Compliance
FDA Fills Advisory Panel Seats As Hill Mulls Laxer Conflict Rules
Washington Drug Letter
As Congress continues to push for more relaxed conflict-of-interest rules for FDA advisory committee members, the agency has reduced the panels’ vacancy rate from 35 percent to 20 percent in the last year.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing